课题基金 / 基金详情

Core A: Lipidomics

Core A: Lipidomics
核心 A:脂质组学
批准号:
9072009
负责人:
ALICJA BIELAWSKA
金额:
$26.6万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30
关键词:
Antineoplastic AgentsApoptosisBiocompatible MaterialsBiologicalBiological AssayBiologyBlood specimenBrainCancer BiologyCancer CenterCell Culture TechniquesCell DeathCellsCeramidaseCeramidesChemicalsCoupledCulture MediaDataData AnalysesDevelopmentDrug TargetingDrug or chemical Tissue DistributionEducational workshopEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesExperimental DesignsFunctional disorderFutureGenerationsGoalsGrowthHigh Pressure Liquid ChromatographyHumanHuman ResourcesImageIn VitroInternationalKidneyLabelLipid ChemistryLipidsLiquid substanceLiverMalignant NeoplasmsMass Spectrum AnalysisMeasurementMeasuresMentorsMetabolicMetabolismMethodologyMethodsMolecularMolecular AnalysisMolecular ProfilingNeoplasm MetastasisNormal CellNormal tissue morphologyOrganOrganellesPathologyPathway interactionsPharmaceutical PreparationsPlasmaPreparationProceduresProtocols documentationRadioactiveRadiolabeledReagentRegulationResearchResearch PersonnelResource SharingResourcesRoleSerumServicesSignal TransductionSiteSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSphingolipidsSphingomyelinaseSphingomyelinsStereoisomerStructureTechnologyTherapeuticTissuesTrainingVertebral columnWorkanalogangiogenesisbasebiobankcancer cellcancer therapycomparativedesigndihydroceramidedrug distributionenzyme activityin vitro activityin vivoinhibitor/antagonistinorganic phosphateinterestlipid mediatorlipid metabolismliquid chromatography mass spectrometrymetabolomicsnovelprogramsradiotracerresearch studyresponsetandem mass spectrometrytherapeutic targettissue preparationtooltumortumor progressiontumor xenograft

项目摘要

项目成果

ALICJA BIELAWSKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY The purpose of the Lipidomics Core in the PPG is to provide intellectual and physical resources (particularly state-of-the-art mass spectrometry analysis of sphingolipids and synthetic molecular tools) to enhance understanding of the role of bioactive lipids in cancer biology with the goal to discover future therapeutics. The diversity of bioactive lipids and their interconnected metabolism generates a network of pathways regulating intra- and inter-cellular signaling and function. Dysfunctions in these pathways contribute to the pathobiology of cancer progression and metastasis. These considerations have necessitated the development of lipid chemistry and analysis. The Lipidomics Core was created based on unique expertise of the key personnel in lipid chemistry, analysis, and metabolism. This Core has developed into an institutional, national, and international resource in the emerging fields of lipidomics and lipid chemical biology. Core services include: 1) Providing qualitative and quantitative analysis of lipid components from different biological materials (cells, tissue, and biological fluids), primarily employing high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) technology—the Core currently provides quantitative analysis of more than 300 distinct lipid molecular species at a basic metabolomic level; 2) Developing and providing synthetic molecular tools to study lipid metabolism (e.g., functionalized and fluorescent ceramides, site-specific radioactive sphingolipids, 17C-sphingolipids) and diversified synthetic lipids and analogs for cellular, in vitro, and in vivo studies (e.g., organelle-targeted sphingolipids and organelle-targeted inhibitors of sphingolipid metabolizing enzymes); 3) Providing direct MALDI-MS tissue analysis to visualize the distribution of lipid based anti-cancer drugs and their molecular effects on sphingolipid components; and 4) Assisting PPG investigators in experimental design, selection of lipids of interest, and interpretation of analytical results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SC COBRE: LIPIDOMICS CORE
SC COBRE: LIPIDOMICS CORE
SC COBRE: LIPIDOMICS CORE
Lipidomics Shared Resource
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: